Nicotine 2 MG Chewing Gum [Habitrol] — RxCUI 2717557
RxNorm drug concept · Semantic branded drug
RxCUI 2717557
Semantic branded drug · SBD
● Current RxNorm concept 3 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2717557
Official nameNicotine 2 MG Chewing Gum [Habitrol]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asHabitrol 2 MG Chewing Gum
FDA products mapped3
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nicotine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You need to stop smoking completely from the moment you start the patch — not cut back gradually. Even when you're not wearing it, nicotine stays in your skin and keeps releasing i...
- Do I need to quit smoking completely on day one, or can I cut back gradually while using the patch?
- You can do either — it depends on how your body reacts. If morning cigarette cravings are strong, wearing it for the full 24 hours can help. But if you're getting vivid dreams or h...
- Can I wear the patch overnight, or should I take it off at bedtime?
🕸️ Concept Web — How Nicotine 2 MG Chewing Gum [Habitrol] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Nicotine 2 MG Chewing Gum [Habitrol]
RxCUI 2717557 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Nicotine
7407IN
-
Nicotine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Habitrol
203781BN
-
Habitrol
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nicotine Chewing Gum
154906SCDF -
Nicotine Chewable Product
1295188SCDG -
Nicotine Oral Product
1158680SCDG -
Nicotine Chewing Gum [Habitrol]
2717263SBDF -
Habitrol Chewable Product
2717262SBDG -
Habitrol Oral Product
2548895SBDG -
Chewing Gum
402499DF -
Chewable Product
1294716DFG - +1 more in this family
-
Nicotine Chewing Gum
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Nicotine 2 MG Chewing Gum
314119SCD -
Nicotine 2 MG
328867SCDC -
Nicotine 2 MG [Habitrol]
2548892SBDC
-
Nicotine 2 MG Chewing Gum
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Nicotine 2 MG Chewing Gum
SCD · 314119 -
Nicotine 2 MG
SCDC · 328867 -
Nicotine Chewing Gum
SCDF · 154906 -
Nicotine Chewable Product
SCDG · 1295188 -
Nicotine Oral Product
SCDG · 1158680
Brand-Name Concepts
-
Nicotine 2 MG [Habitrol]
SBDC · 2548892 -
Nicotine Chewing Gum [Habitrol]
SBDF · 2717263 -
Habitrol Chewable Product
SBDG · 2717262 -
Habitrol Oral Product
SBDG · 2548895 -
Habitrol
BN · 203781
📦 FDA Products & Package NDCs
3 products · 9 package NDCs
9 package NDCs map to RxCUI 2717557 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 55741-0004-10 | 10 GUM, CHEWING in 1 BLISTER PACK (55741-004-10) | Habitrol Nicotine Polacrilex 2 mg Coated Cinnamon | Dr. Reddy's Laboratories Inc. | 2025-07-28 |
| 55741-0004-15 | 15 BLISTER PACK in 1 CARTON (55741-004-15) / 10 GUM, CHEWIN... | Habitrol Nicotine Polacrilex 2 mg Coated Cinnamon | Dr. Reddy's Laboratories Inc. | 2025-07-28 |
| 55741-0004-80 | 8 BLISTER PACK in 1 CARTON (55741-004-80) / 10 GUM, CHEWING... | Habitrol Nicotine Polacrilex 2 mg Coated Cinnamon | Dr. Reddy's Laboratories Inc. | 2025-07-28 |
| 75907-0301-10 | 10 GUM, CHEWING in 1 BLISTER PACK (75907-301-10) | Habitrol Nicotine Polacrilex Gum 2 mg Coated Fruit | Dr. Reddy's Laboratories Inc. | 2025-06-12 |
| 75907-0301-15 | 15 BLISTER PACK in 1 CARTON (75907-301-15) / 10 GUM, CHEWIN... | Habitrol Nicotine Polacrilex Gum 2 mg Coated Fruit | Dr. Reddy's Laboratories Inc. | 2025-06-12 |
| 75907-0301-80 | 8 BLISTER PACK in 1 CARTON (75907-301-80) / 10 GUM, CHEWING... | Habitrol Nicotine Polacrilex Gum 2 mg Coated Fruit | Dr. Reddy's Laboratories Inc. | 2025-06-12 |
| 75907-0302-10 | 10 GUM, CHEWING in 1 BLISTER PACK (75907-302-10) | Habitrol Nicotine Polacrilex Gum 2 mg Coated Mint | Dr. Reddy's Laboratories Inc. | 2025-06-12 |
| 75907-0302-15 | 15 BLISTER PACK in 1 CARTON (75907-302-15) / 10 GUM, CHEWIN... | Habitrol Nicotine Polacrilex Gum 2 mg Coated Mint | Dr. Reddy's Laboratories Inc. | 2025-06-12 |
| 75907-0302-80 | 8 BLISTER PACK in 1 CARTON (75907-302-80) / 10 GUM, CHEWING... | Habitrol Nicotine Polacrilex Gum 2 mg Coated Mint | Dr. Reddy's Laboratories Inc. | 2025-06-12 |
Observed labelers:
Dr. Reddy's Laboratories Inc. (9)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.